Come up with a name for your new list and we'll add to it:
Oxford BioTherapeutics raised a round of funding on July 30, 2015. Investors include
Silicon Valley Bank.
Oxford BioTherapeutics is an international, clinical-stage biotechnology company focused on developing antibody-based therapies to treat cancer. Combining immuno-oncology, antibody-drug conjugates, an…